683-Targeting TRBC2 for the Treatment of T Cell Cancers

This research article introduces a novel antibody-drug conjugate (ADC) designed to treat T cell cancers by targeting the TRBC2 constant region of the T cell receptor. Unlike existing treatments that deplete all T cells and cause severe immunosuppression, this therapy exploits the fact that individual T cell malignancies express only one of two possible alleles, either TRBC1 or TRBC2. By engineerin...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动